• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病的全球负担及未来方向

The global burden of chronic kidney disease and the way forward.

作者信息

Alebiosu C O, Ayodele O E

机构信息

Department of Medicine, Olabisi Onabanjo University Teaching Hospital, Ibadan, Oyo State, Nigeria.

出版信息

Ethn Dis. 2005 Summer;15(3):418-23.

PMID:16108301
Abstract

BACKGROUND

Chronic kidney disease (CKD) is increasing worldwide at an annual growth rate of 8%. Regional differences exist in the epidemiology of the condition, and non-Whites are more affected.

METHODS

An English-language literature search using Medline (January 1984-October 2003) was done to assess research/review articles on burden and prevention of CKD. Particular attention was paid to epidemiology and prevention of chronic kidney diseases.

RESULTS

The prevalence of CKD is higher in developing countries than in the developed world. The most common causes of CKD in the developing countries are chronic glomerulonephritis and systemic hypertension, diabetic nephropathy being the most common cause in Europe, the United States, and Japan. Factors contributing to the regional differences in the etiology and prevalence of CKD are race and ethnicity, genetic predisposition, increasing prevalence of type 2 diabetes, mortality caused by other disease, obesity, and possibly cigarette smoking. The control of hypertension, dyslipidemia, proteinuria, obesity, avoidance of low birth weight, smoking, and preventing ingesting of heavy metals such as lead are intervention strategies that retard or prevent progression of renal diseases. The magnitude of the existing burden of illness caused by renal failure, the projections for increasing incidence of CKD, and the limitations of our existing treatments for renal insufficiency all point to the need for clinical and population-based interventions aimed at prevention of CKD.

CONCLUSIONS

A comprehensive health education campaign and screening of the general populace are needed in order to detect chronic kidney disease early. These measures will ensure appropriate and timely institution of proven measures to halt or reduce progression of CKD.

摘要

背景

慢性肾脏病(CKD)在全球范围内正以每年8%的增长率上升。该疾病的流行病学存在地区差异,非白种人受影响更大。

方法

利用Medline(1984年1月至2003年10月)进行英文文献检索,以评估关于CKD负担及预防的研究/综述文章。特别关注慢性肾脏病的流行病学和预防。

结果

发展中国家CKD的患病率高于发达国家。发展中国家CKD最常见的病因是慢性肾小球肾炎和系统性高血压,而在欧洲、美国和日本,糖尿病肾病是最常见的病因。导致CKD病因和患病率存在地区差异的因素包括种族和民族、遗传易感性、2型糖尿病患病率上升、其他疾病导致的死亡率、肥胖,以及可能的吸烟。控制高血压、血脂异常、蛋白尿、肥胖,避免低出生体重、吸烟,以及防止摄入铅等重金属是延缓或预防肾脏疾病进展的干预策略。肾衰竭导致的现有疾病负担程度、CKD发病率上升的预测,以及我们现有肾功能不全治疗方法的局限性,都表明需要开展以临床和人群为基础的干预措施来预防CKD。

结论

需要开展全面的健康教育活动并对普通民众进行筛查,以便早期发现慢性肾脏病。这些措施将确保适时采取经证实的措施来阻止或减缓CKD的进展。

相似文献

1
The global burden of chronic kidney disease and the way forward.慢性肾脏病的全球负担及未来方向
Ethn Dis. 2005 Summer;15(3):418-23.
2
Burden of chronic kidney disease: an international perspective.慢性肾脏病负担:国际视角。
Adv Chronic Kidney Dis. 2010 May;17(3):215-24. doi: 10.1053/j.ackd.2010.02.001.
3
[Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital].[刚果民主共和国慢性肾脏病流行病学:首都金沙萨横断面研究综述]
Nephrol Ther. 2010 Jul;6(4):232-9. doi: 10.1016/j.nephro.2010.03.008. Epub 2010 Apr 20.
4
The global burden of chronic kidney disease: how valid are the estimates?慢性肾脏病的全球负担:这些估算有多准确?
Nephron Clin Pract. 2008;110(1):c39-46; discussion c47. doi: 10.1159/000151244. Epub 2008 Aug 8.
5
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.
6
[New concept of chronic kidney disease and blockade of renin-angiotensin system].[慢性肾脏病的新概念与肾素-血管紧张素系统阻断]
Nihon Rinsho. 2007 Sep;65(9):1727-33.
7
Surveillance of chronic kidney disease around the world: tracking and reining in a global problem.全球慢性肾脏病监测:追踪并控制这一全球性问题。
Adv Chronic Kidney Dis. 2010 May;17(3):271-81. doi: 10.1053/j.ackd.2010.03.001.
8
[Progression factors for chronic kidney disease. Secondary prevention].[慢性肾脏病的进展因素。二级预防]
Nefrologia. 2008;28 Suppl 3:17-21.
9
Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.预防慢性肾脏病发生、进展及并发症的综合公共卫生策略:疾病控制与预防中心召集的专家小组报告
Am J Kidney Dis. 2009 Mar;53(3):522-35. doi: 10.1053/j.ajkd.2008.11.019.
10
Epidemiology, impact and preventive care of chronic kidney disease in Taiwan.台湾地区慢性肾脏病的流行病学、影响因素与预防保健。
Nephrology (Carlton). 2010 Jun;15 Suppl 2:3-9. doi: 10.1111/j.1440-1797.2010.01304.x.

引用本文的文献

1
The global burden of chronic kidney disease due to glomerulonephritis: trends and predictions.全球肾小球肾炎所致慢性肾脏病的负担:趋势与预测
Int Urol Nephrol. 2025 Jul 18. doi: 10.1007/s11255-025-04669-x.
2
Assessing Renal Function in Chronic Kidney Disease: A Comparative Evaluation of Glomerular Filtration Rate Prediction Equations in the North-Central Region of Nigeria.评估慢性肾脏病患者的肾功能:尼日利亚中北部地区肾小球滤过率预测方程的比较评价
Cureus. 2025 May 21;17(5):e84577. doi: 10.7759/cureus.84577. eCollection 2025 May.
3
Chronic kidney disease among patients with hypertension in sub-Saharan Africa: a systematic review and meta-analysis.
撒哈拉以南非洲高血压患者中的慢性肾脏病:一项系统评价和荟萃分析。
BMC Public Health. 2025 May 1;25(1):1603. doi: 10.1186/s12889-025-22828-8.
4
Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort.从风险因素到结局,探寻终末期肾病(ESKD)的复杂性:来自英国生物银行队列的见解
BMC Nephrol. 2025 Apr 1;26(1):168. doi: 10.1186/s12882-025-04090-7.
5
Human Immunodeficiency Virus-positive Patients on Highly Active Antiretroviral Therapy Continue to Have a Decline in Renal Function Irrespective of Tenofovir Usage.接受高效抗逆转录病毒治疗的人类免疫缺陷病毒阳性患者,无论是否使用替诺福韦,其肾功能均持续下降。
J Glob Infect Dis. 2024 Sep 27;16(3):111-116. doi: 10.4103/jgid.jgid_125_23. eCollection 2024 Jul-Sep.
6
Knowledge, attitude and practices towards prevention and early detection of chronic kidney disease and associated factors in Ethiopia: A cross-sectional study.埃塞俄比亚对慢性肾脏病预防和早期检测的知识、态度及实践及其相关因素:一项横断面研究。
J Public Health Res. 2024 Sep 9;13(3):22799036241277088. doi: 10.1177/22799036241277088. eCollection 2024 Jul.
7
Single versus bilateral internal thoracic artery grafting in patients with impaired renal function.肾功能受损患者的单支与双侧胸廓内动脉桥接。
PLoS One. 2024 Feb 14;19(2):e0297194. doi: 10.1371/journal.pone.0297194. eCollection 2024.
8
Ocular manifestations in renal diseases.肾脏疾病的眼部表现。
Indian J Ophthalmol. 2023 Aug;71(8):2938-2943. doi: 10.4103/IJO.IJO_3234_22.
9
Health-related quality of life among patients with end-stage renal disease undergoing hemodialysis in Ethiopia: a cross-sectional survey.埃塞俄比亚终末期肾病血液透析患者的健康相关生活质量:一项横断面调查。
Health Qual Life Outcomes. 2023 Apr 17;21(1):36. doi: 10.1186/s12955-023-02117-x.
10
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease.应用生理药代动力学模型预测慢性肾脏病儿童卡托普利的处置。
Sci Rep. 2023 Feb 15;13(1):2697. doi: 10.1038/s41598-023-29798-0.